PE20060351A1 - Oxazolidinonas que contienen oxindoles como agentes antibacterianos - Google Patents

Oxazolidinonas que contienen oxindoles como agentes antibacterianos

Info

Publication number
PE20060351A1
PE20060351A1 PE2005000905A PE2005000905A PE20060351A1 PE 20060351 A1 PE20060351 A1 PE 20060351A1 PE 2005000905 A PE2005000905 A PE 2005000905A PE 2005000905 A PE2005000905 A PE 2005000905A PE 20060351 A1 PE20060351 A1 PE 20060351A1
Authority
PE
Peru
Prior art keywords
oxo
antibacterial agents
oxazolidine
indol
dihydro
Prior art date
Application number
PE2005000905A
Other languages
English (en)
Inventor
Gary Wayne Luehr
Rama Jain
Vara Prasad Venkata Nagendra Josyula
Mikhail Fedorovich Gordeev
Adam Robert Renslo
Original Assignee
Pharmacia And Upjohn Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35079333&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20060351(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia And Upjohn Company Llc filed Critical Pharmacia And Upjohn Company Llc
Publication of PE20060351A1 publication Critical patent/PE20060351A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

REFERIDA A UN COMPUESTO DERIVADO DE OXAZOLIDINONA DE FORMULA I, DONDE Y1 ES -CH- O -CF-; R1 ES ALQUILO C1-C4, SUSTITUIDO OPCIONALMENTE CON UN ATOMO DE FLUORO O R1 ES CICLOALQUILO C3-C5; R2 ES H O CH3. SON COMPUESTOS PREFERIDOS: (5R)-3-(1-ISOPROPIL-2-OXO-2,3-DIHIDRO-1H-INDOL-5-IL)-2-OXO-OXAZOLIDINA-5-CARBOXILICO, AMIDA DEL ACIDO (5R)-3-(1-METIL-2-OXO-2,3-DIHIDRO-1H-INDOL-5-IL)-2-OXO-OXAZOLIDINA-5-CARBOXILICO, AMIDA DEL ACIDO (5R)-3-(7-FLUORO-1-METIL-2-OXO-2,3-DIHIDRO-1H-INDOL-5-IL)-2-OXO-OXAZOLIDINA-5-CARBOXILICO, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON UTILES COMO AGENTES ANTIBACTERIANOS EN EL TRATAMIENTO DE INFECCIONES MICROBIANAS GRAM-POSITIVAS O GRAM-NEGATIVAS
PE2005000905A 2004-08-06 2005-08-03 Oxazolidinonas que contienen oxindoles como agentes antibacterianos PE20060351A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59982204P 2004-08-06 2004-08-06

Publications (1)

Publication Number Publication Date
PE20060351A1 true PE20060351A1 (es) 2006-05-03

Family

ID=35079333

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000905A PE20060351A1 (es) 2004-08-06 2005-08-03 Oxazolidinonas que contienen oxindoles como agentes antibacterianos

Country Status (24)

Country Link
US (2) US20080262056A1 (es)
EP (2) EP1781642A1 (es)
JP (2) JP2008509126A (es)
CN (1) CN101001853A (es)
AP (1) AP2007003904A0 (es)
AR (1) AR050101A1 (es)
AU (1) AU2005270951A1 (es)
BR (2) BRPI0513083A (es)
CA (2) CA2575702A1 (es)
EA (1) EA200700322A1 (es)
GT (1) GT200500204A (es)
IL (1) IL180957A0 (es)
MA (1) MA28793B1 (es)
MX (2) MX2007001526A (es)
NL (1) NL1029686C2 (es)
NO (1) NO20071230L (es)
PA (1) PA8640901A1 (es)
PE (1) PE20060351A1 (es)
SV (1) SV2006002180A (es)
TN (1) TNSN07043A1 (es)
TW (1) TWI289448B (es)
UY (1) UY29048A1 (es)
WO (2) WO2006016220A1 (es)
ZA (1) ZA200700476B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007011873A (es) * 2005-04-06 2007-11-07 Pharmacia & Upjohn Co Llc Una oxindoloxazolidinona como agente antibacteriano.
AU2006231919A1 (en) * 2005-04-06 2006-10-12 Pharmacia & Upjohn Company Llc 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
CN103483329B (zh) * 2013-09-07 2015-08-05 吉首大学 呋喃酮-芳基-噁唑烷酮型化合物及其制法和用途
CN103420995B (zh) * 2013-09-07 2015-07-01 吉首大学 噁唑烷酮-烷胺基-呋喃酮型化合物及其制法和用途
CN111018840B (zh) * 2017-10-25 2022-09-09 西南大学 3-咪唑取代的靛红唑醇类化合物及其制备方法和医药应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617871B2 (en) * 1988-09-15 1991-12-05 Pharmacia & Upjohn Company In position 3 substituted-5-beta-amidomethyl-oxazolidin-2- ones
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
BR9509673A (pt) * 1994-11-15 1997-09-30 Upjohn Co Compostos e uso dos mesmos
HRP960159A2 (en) * 1995-04-21 1997-08-31 Bayer Ag Benzocyclopentane oxazolidinones containing heteroatoms
RU2175324C2 (ru) * 1995-09-01 2001-10-27 Фармация Энд Апджон Компани Фенилоксазолидиноны, имеющие с-с-связь с 4-8-членными гетероциклическими кольцами
DE19601265A1 (de) * 1996-01-16 1997-07-17 Bayer Ag 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone
DE19601627A1 (de) * 1996-01-18 1997-07-24 Bayer Ag Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB9609919D0 (en) * 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
DE69716925T2 (de) * 1996-08-21 2003-09-11 Pharmacia & Upjohn Co., Kalamazoo Isoxazoline derivate und ihre verwendung als antimikroben
GB9717804D0 (en) * 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
KR20010015910A (ko) * 1998-01-23 2001-02-26 로렌스 티. 마이젠헬더 옥사졸리디논 조합 라이브러리, 조성물 및 제조 방법
GB9812019D0 (en) * 1998-06-05 1998-07-29 Zeneca Ltd Chemical compounds
EP1149089B1 (en) * 1999-02-01 2003-03-26 PHARMACIA & UPJOHN COMPANY PROCESS TO PREPARE TETRAHYDROTHIOPYRAN-o-FLUORINATED CARBAMATES
ES2203473T3 (es) * 1999-05-27 2004-04-16 PHARMACIA & UPJOHN COMPANY Oxazolidinonas biciclicas como agentes antibacterianos.
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7012088B2 (en) * 2003-02-24 2006-03-14 Pharmacia & Upjohn Company Indolone oxazolidinones and derivatives thereof
AU2006231919A1 (en) * 2005-04-06 2006-10-12 Pharmacia & Upjohn Company Llc 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents

Also Published As

Publication number Publication date
IL180957A0 (en) 2007-07-04
AU2005270951A1 (en) 2006-02-16
EA200700322A1 (ru) 2007-08-31
WO2006016220A1 (en) 2006-02-16
NO20071230L (no) 2007-05-04
CA2576041A1 (en) 2006-02-16
MX2007001526A (es) 2007-03-27
AR050101A1 (es) 2006-09-27
CN101001853A (zh) 2007-07-18
PA8640901A1 (es) 2007-01-17
TWI289448B (en) 2007-11-11
SV2006002180A (es) 2006-06-26
MX2007001568A (es) 2007-04-16
EP1781643A1 (en) 2007-05-09
NL1029686A1 (nl) 2006-02-07
US20080262056A1 (en) 2008-10-23
US20060030609A1 (en) 2006-02-09
UY29048A1 (es) 2006-03-31
ZA200700476B (en) 2008-10-29
WO2006016221A1 (en) 2006-02-16
BRPI0513083A (pt) 2008-04-22
GT200500204A (es) 2006-03-02
MA28793B1 (fr) 2007-08-01
JP2008509126A (ja) 2008-03-27
BRPI0514020A (pt) 2008-05-27
EP1781642A1 (en) 2007-05-09
CA2575702A1 (en) 2006-02-16
TNSN07043A1 (fr) 2008-06-02
NL1029686C2 (nl) 2006-07-18
AP2007003904A0 (en) 2007-02-28
TW200612924A (en) 2006-05-01
JP2008509125A (ja) 2008-03-27

Similar Documents

Publication Publication Date Title
PE20110150A1 (es) Amidofenoxiindazoles como inhibidores de c-met
PE20090772A1 (es) Derivados de bencimidazol
PE20091843A1 (es) Inhibidores de catepsina c
CO6450621A2 (es) Sulfonamidas nematocidas
PE20081753A1 (es) Compuestos y composiciones como inhibidores de la proteasa activadora de canal
PE20120355A1 (es) DERIVADOS DE PIRAZOL COMO INHIBIDORES DE LA ENZIMA 11ßHSD1
PE20091816A1 (es) Inhibidores de bace
PE20070367A1 (es) Compuestos de espiropiperidina como inhibidores de la enzima beta secretasa
PE20191020A1 (es) Compuestos quimicos
PE20201256A1 (es) Compuestos monobactamicos cromanos para el tratamiento de infecciones bacterianas
PE20131117A1 (es) Derivados de bencimidazol como inhibidores de prostaglandinas
EA200970510A1 (ru) Гетеромоноциклическое соединение и его применение
PE20090601A1 (es) Derivados de piridin-il-oxi-piridinas como inhibidores de alk5
PE20081345A1 (es) Compuestos heterociclicos que contienen nitrogeno como agonistas del receptor nicotinico
PE20091339A1 (es) Derivados de oxadiazol con actividad sobre receptores s1p1
PE20051054A1 (es) Compuestos heterociclicos utiles como secretagogos de la hormona de crecimiento
PE20061490A1 (es) Derivados de ciclohexanosulfonilo como inhibidores del transportador de glicina glyt1
PE20060692A1 (es) Inhibidores bace
PE20060937A1 (es) Derivados de sulfonilbencimidazol como agonistas del receptor cannabinoide 2 (cb2)
PE20120054A1 (es) COMPUESTOS DERIVADOS DE 4,8-DIHIDRO-4,7-METANO-7H-PIRAZOLO[3,4-e][1,3]DIAZEPINA-6(5H)-ONA CON ACTIVIDAD ANTIBACTERIANA
PE20080283A1 (es) Profarmacos antimicrobianos de oxazolidinona
PE20070814A1 (es) Compuestos derivados de 2-carboxitiofeno como inhibidores de la polimerasa del virus de la hepatitis c (hcv)
PE20221486A1 (es) Tieniloxazolonas y analogos
PE20080143A1 (es) Compuestos 2-oxo-3-fenil-(1,4-diazaespiro[4.5]dec-3-en-1-il)acetamida sustituidos como inhibidores del transportador de glicina
PE20080207A1 (es) DERIVADOS DE 1-N-AMINO-2-IMIDAZOLIDINONAS COMO INHIBIDORES DEL CANAL DE POTASIO Kv1.5

Legal Events

Date Code Title Description
FC Refusal